AUTL catalysts
Catalysts and events linked to AUTL, newest first.
AUTL stock catalysts and risks
Latest published review: 2026-10-20
| Development | Transmission channel | Evidence | Condition to watch |
|---|---|---|---|
| CAR-T oncology market expands as ALL and lymphoma therapies target long-term growth 2026-09-16 · Up | commercial adoption of Aucatzyl in acute lymphoblastic leukemia | Autolus Aucatzyl identified as emerging therapy in CAR-T ALL market. | Not recorded |
Do these developments change your position?
Review AUTL alongside your other holdings and identify which decision deserves attention first.
Review your initial audit before choosing ongoing portfolio scanning at $79/month.
DateCardAvg 5d
- 2026-09-16CAR-T oncology market expands as ALL and lymphoma therapies target long-term growthAUTL GILD NVS
- 2026-09-16CAR-T oncology market expands as ALL and lymphoma therapies target long-term growthAUTL GILD NVS
See today's live cards
Public pages are published 24 hours after the product shows them. Desk shows every catalyst, event and causal reading as it happens, mapped to your holdings.